LipAD lipid-assembled delivery system
Total Trials
19
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,836
NCT00747474
Phase I Study of Intravenous Lipotecan® (TLC388 HCl for Injection) in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2008
Completion: Dec 31, 2011
NCT01425996
A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Phase: Phase 1/2
Start: Oct 27, 2011
Completion: Oct 3, 2014
NCT01652859
An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects
Start: Feb 29, 2012
Completion: Dec 31, 2012
NCT01831973
A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients
Phase: Phase 2
Start: Nov 30, 2012
Completion: Feb 21, 2017
NCT02267213
Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma
Start: Apr 10, 2014
Completion: Jul 9, 2015
NCT02006147
Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO
Start: Nov 30, 2014
Completion: Jul 15, 2020
NCT02803307
Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee
Start: Jun 30, 2015
Completion: Nov 30, 2016
NCT03005873
Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients
Start: Mar 16, 2017
Completion: Jul 4, 2018
NCT03093701
TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Start: Apr 1, 2017
Completion: Feb 4, 2019
NCT03035006
Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
Start: Apr 14, 2017
Completion: Oct 31, 2018
NCT02925000
Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy
Start: Jun 19, 2017
Completion: Oct 6, 2020
NCT03591146
Phase I/II Dose-escalation Study to Evaluate Safety, PK and Efficacy of TLC590 for Postsurgical Pain Management
Start: Jul 31, 2018
Completion: Jan 14, 2019
NCT03641131
Ampholipad Real-World Data in Taiwan
Phase: N/A
Start: Sep 9, 2018
Completion: Jan 8, 2019
NCT03754049
A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee
Start: Jan 21, 2019
Completion: Nov 7, 2023
NCT03838133
A Study to Evaluate Safety, PK, Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy
Start: Mar 5, 2019
Completion: Mar 31, 2020
NCT04123561
Extended and Controlled Release Liposomal Formulated Dexamethasone for Chronic Knee OA Pain
Phase: Phase 3
Start: Nov 26, 2019
Completion: Feb 3, 2022
NCT04697654
The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers
Start: Oct 8, 2020
Completion: Jun 18, 2021
NCT06574269
A Study on TLC590 for Managing Postsurgical Pain
Start: Sep 30, 2024
Completion: Aug 31, 2026
NCT05161637
Phase 2/3 Study of TLC590 for Postsurgical Pain Management
Phase: Phase 2/3
Start: Apr 30, 2025
Completion: Dec 31, 2025
Loading map...